CTLA4 and cancer: However, some cancers have developed methods to escape the immune system via increased expression of inhibitory immune checkpoints, such as programmed cell death ligands 1 and 2 (PD-L1, PD-L2) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4).